Duke Institute of Cancer — Durham, North Carolina

Duke Institute of Cancer is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Institute of Cancer has participated in 1 clinical trials.

Therapeutic areas: Dedifferentiated Liposarcoma.

Sponsors: Karyopharm Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Institute of Cancer?

Duke Institute of Cancer has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Institute of Cancer conducted?

Duke Institute of Cancer has 1 clinical trials on record. Their work covers Dedifferentiated Liposarcoma.

Is Duke Institute of Cancer accredited by Crixeo Health?

Duke Institute of Cancer has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Institute of Cancer?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.